The Patent Lawyer
IP Knowledge HubA hub of global IP knowledge updated by professionals. To publish on these pages please contact [email protected]
Insights and Best Practices in IP – Life Sciences Field | 2026 Report
by Insight IP | Feb 5, 2026
How leading life sciences IP teams are adapting to complexity, risk, and rapid change Download the full report to...
More than 100 companies join Open Invention Network as it evolves to OIN 2.0
by Open Invention Network | Jan 27, 2026
Since 2005, Open Invention Network (OIN) has continued in its mission of protecting and promoting open source software...
The corporate IP tech stack 2026: what in-house teams should demand from AI tools
by DeepIP | Jan 26, 2026
By 2026, artificial intelligence will no longer be a “nice to have” in corporate IP departments. It will be a baseline...
The hidden cost of missed inventions: how AI helps corporations capture R&D innovation before it disappears
by DeepIP | Jan 14, 2026
For most large R&D-driven organizations, the biggest innovation risk is not competitors—it is silence. Every year,...
The cognitive era: the next Industrial Revolution is powered by thought, not engines
by Anaqua | Jan 5, 2026
AI adoption isn't just a passing trend; it is an irreversible shift in human productivity and creativity. We have...
Modernizing IP management and overcoming key challenges with AI-powered solutions
by Anaqua | Dec 10, 2025
Intellectual property (IP) teams are crucial for promoting and safeguarding the company’s strategic assets....
The evolution of AI in IP: what has changed
by Clarivate | Dec 9, 2025
An analysis of practitioner sentiment, adoption patterns, and the governance challenges shaping AI’s role in IP...
Corporate IP strategy: how AI helps prioritize patent filings under budget constraints
by DeepIP | Dec 1, 2025
In-house IP teams across sectors—from life sciences to advanced manufacturing, materials, and software—are facing a...
Enhanced by AI, comprehensive IP management systems are the superior choice
by Anaqua | Nov 17, 2025
Currently, many organizations are attempting to address their diverse intellectual property (IP) needs by implementing...
The semaglutide saga continues: navigating generic entry and reinforcing patent strategies in Canada
by Brunet & Co. | Nov 14, 2025
In our July 2025 analysis, “The Semaglutide Story: Highlighting the Need to Maintain Patent Protection in Canada,” we...
Contact us to publish in The IP Knowledge hub


















